Public interest is piqued over AI-aided cancer detection. 

Patient outcomes, safety data and physician feedback were all used to rank the top children's hospitals for pediatric cardiology and heart surgery in the United States. Did your facility make the cut? 

As 2024 winds down and the number of FDA-approved medical devices packing AI approaches 1,000—the agency had the tally at 950 as of August—the industry finds itself at a “critical inflection point.” 

Deep fakes are more dangerous to healthcare than we may have thought. 

Nurses tend to feel optimistic if not exactly excited about AI’s advances into their profession. Those who hold back tend to share a common concern—sacrificing care quality for the sake of tech-enabled efficiency. 

The Accelerating Kids' Access to Care Act would expand Medicaid access for pediatric patients so that it covers interventional cardiologists outside of their home states.

AI didn’t displace the nearly 3,000 people who just lost their jobs at CVS. 

Generative AI is fixing to transform the pharmaceutical industry. However, not all adopters will reap rewards in comparable degrees.